New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
15:34 EDTARNAArena Pharmaceuticals drops after CHMP issues recommendations
The stock is down over 5.4% at time of writing, edging toward session lows. At the current price of $9.87, next support is at $9.47. Resistance is at the 10-day moving average, last at $10.03.
News For ARNA From The Last 14 Days
Check below for free stories on ARNA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2014
14:04 EDTARNAWorldwide Business Research to hold a conference
Subscribe for More Information
August 29, 2014
11:04 EDTARNAArena pulmonary arterial hypertension treatment granted orphan designation
The FDA granted orphan designation to Arena Pharmaceuticals' treatment of pulmonary arterial hypertension, according to a post to the agency's site. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use